12/5/2025Recent Executive Moves

12/4/2025Simcere Secures Greater China Rights to Vigonvita's VV116 Dry Suspens...

12/4/2025China's Healthcare Costs Shift to Individuals as Government Share Decl...

12/3/2025WuXi Biologics Extends Global CRDMO Network to Qatar

12/2/2025China Used to Be a Cash Cow for Western Companies. Now It's a Test Lab...

12/2/2025NHC Releases 2024 China Health Statistics Bulletin

12/2/2025China Launches National Drug Price Registration System to Propel Marke...

12/1/2025MNC's County-Level Ambitions Falter as Strategies Shift From Heavy Inv...

11/28/2025China Expands Grassroots Healthcare Access with More Doctors, Mobile S...

11/28/2025Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...

11/28/2025Recent Executive Moves

11/27/2025Sugemalimab Wins European Approval for Stage III NSCLC

11/27/2025CSPC's JMT206 Wins Green Light for First-in-Human Trials in China

11/27/2025Biontech to Present Phase 2 Data for Bispecific Antibody Pumitamig in ...

11/27/2025NMPA Approves AstraZeneca's Imfinzi for NSCLC in China

11/27/2025Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST

11/27/2025Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...

11/27/2025GlobalData: Ivonescimab Poised to Transform China's TNBC Market

11/27/2025Olymvax Files for Hong Kong Listing as Vaccine Pipeline Expands

11/27/2025MC's China Biopharma Tracker: Dealmaking, Approvals, and $451 Million ...

11/25/2025Reprogenix Raises CNY 500M in A+ Round to Push Forward First-In-China...

11/25/2025Pfizer's Hympavzi (Marstacimab) Gains NMPA Approval in China

11/25/2025BioCorteX and CD Biopharma Form Strategic Alliance to Accelerate Preci...

11/25/2025Amicus Diversifies Manufacturing from China to Reduce Geopolitical Ris...

11/25/2025Samsung LS Fund Invests in Phrontline to Boost ADC Development

11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...

11/25/2025China Accelerates Investment in Nuclear Medicine Amid Global Radiophar...

11/21/2025Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...

11/21/2025Xiangxue Expands Into In Vivo TCR-T Therapy Through New Partnership

11/21/2025Recent Executive Moves

Page:1/373 Total number of articles:11175: [First][<<] [1] [2] [3] [4] [5] [>>] [End]